Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Scholar Rock
< Previous
1
2
3
Next >
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 15, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress
November 12, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
November 01, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Participate in Upcoming Investor Conferences
October 31, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting
October 31, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering
October 22, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 18, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants
October 08, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
October 07, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)
October 07, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 13, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Completes Enrollment in Phase 2 EMBRAZE Proof-of-Concept Trial of Apitegromab in Obesity
September 10, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Appoints Beth Shafer, Ph.D., to Chief Business Officer
September 04, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Participate in Upcoming Investor Conferences
August 29, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 16, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Second Quarter 2024 Financial Results and Highlights Business Progress
August 08, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
July 23, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 12, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces New SRK-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal
June 24, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Presents New Data from SRK-181 Phase 1 DRAGON Trial at ASCO 2024 Annual Meeting
June 03, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Present New Data from SRK-181 Phase 1 DRAGON Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 28, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegromab in Obesity and New Preclinical Data Supporting SRK-439 in Obesity
May 22, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Participate in Upcoming Investor Conferences
May 20, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Host Investor Day on May 22, 2024
May 14, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress
May 07, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 12, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
March 19, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
Scholar Rock to Participate in Upcoming Investor Conferences
February 28, 2024
From
Scholar Rock
Via
Business Wire
Tickers
SRRK
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.